S 033447
Alternative Names: S-033447Latest Information Update: 28 May 2021
Price :
$50 *
At a glance
- Originator Shionogi
- Class Antivirals; Small molecules
- Mechanism of Action Endonuclease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Influenza A virus H5N1 subtype; Influenza A virus infections; Influenza B virus infections
Most Recent Events
- 28 May 2021 No recent reports of development identified for preclinical development in Influenza-A-virus-H5N1-subtype in Japan (PO)
- 28 Nov 2020 No recent reports of development identified for preclinical development in Influenza-A-virus-infections in Japan (PO)
- 28 Nov 2020 No recent reports of development identified for preclinical development in Influenza-B-virus-infections in Japan (PO)